These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37124623)

  • 101. A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma.
    Chen S; Liu P; Zhao L; Han P; Liu J; Yang H; Li J
    Front Immunol; 2022; 13():954653. PubMed ID: 36189204
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Tumour Immune Analysis in Osteosarcoma.
    Jiang J; Chu D; Lai X; Liu L; Tao J
    Comput Math Methods Med; 2022; 2022():6314182. PubMed ID: 36388161
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Establishment and validation of a cuproptosis-related lncRNA signature that predicts prognosis and potential targeted therapy in hepatocellular carcinoma.
    Guo DF; Fan LW; Zeng HH; Huang CB; Wu XH
    Biotechnol Genet Eng Rev; 2023 Mar; ():1-26. PubMed ID: 36951200
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer.
    Liu L; Zheng J; Xia H; Wu Q; Cai X; Ji L; Sun Y
    Front Genet; 2023; 14():1023613. PubMed ID: 36777734
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer.
    Jin L; Mei W; Liu X; Sun X; Xin S; Zhou Z; Zhang J; Zhang B; Chen P; Cai M; Ye L
    Front Immunol; 2022; 13():974034. PubMed ID: 36203594
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma.
    Chen Y; Tang L; Huang W; Abisola FH; Zhang Y; Zhang G; Yao L
    Biol Direct; 2023 Feb; 18(1):4. PubMed ID: 36750831
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Integrated machine learning and bioinformatic analyses used to construct a copper-induced cell death-related classifier for prognosis and immunotherapeutic response of hepatocellular carcinoma patients.
    Zhao S; Chen S; Liu W; Wei S; Wu X; Cui D; Jiang L; Chen S; Wang J
    Front Pharmacol; 2023; 14():1188725. PubMed ID: 37266152
    [No Abstract]   [Full Text] [Related]  

  • 108. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
    Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
    Front Immunol; 2022; 13():998236. PubMed ID: 36110851
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The Prognostic Role of Cuproptosis in Head and Neck Squamous Cell Carcinoma Patients: A Comprehensive Analysis.
    Ding Q; Chen X; Hong W; Wang L; Liu W; Cai S; Chen X; Lu J; Qiu S
    Dis Markers; 2022; 2022():9996946. PubMed ID: 36092958
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.
    Liu J; Ji C; Wang Y; Zhang C; Zhu H
    Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 112. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Prediction model of clinical prognosis and immunotherapy efficacy of gastric cancer based on level of expression of cuproptosis-related genes.
    Zhao B; Wu W; Liang L; Cai X; Chen Y; Tang W
    Heliyon; 2023 Aug; 9(8):e19035. PubMed ID: 37636385
    [TBL] [Abstract][Full Text] [Related]  

  • 114. An effective prognostic model in colon adenocarcinoma composed of cuproptosis-related epigenetic regulators.
    Liu Y; Wang Y; Li C; Feng H; Liu Y; Ma L
    Front Pharmacol; 2023; 14():1254918. PubMed ID: 37701039
    [No Abstract]   [Full Text] [Related]  

  • 115. Comprehensive analysis of cuproptosis-related genes in prognosis, tumor microenvironment infiltration, and immunotherapy response in gastric cancer.
    Nie H; Wang H; Zhang M; Ning Y; Chen X; Zhang Z; Hu X; Zhao Q; Chen P; Fang J; Wang F
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5453-5468. PubMed ID: 36462036
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment.
    Duan H; Shen Y; Wang C; Xia W; Zhang S; Yu S; Xu D; Cao Q; Liu H; Shen H
    Int J Gen Med; 2024; 17():161-174. PubMed ID: 38268861
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Cuproptosis-related lncRNAs as potential biomarkers of AML prognosis and the role of lncRNA HAGLR/miR-326/CDKN2A regulatory axis in AML.
    Du A; Yang Q; Luo X
    Am J Cancer Res; 2023; 13(9):3921-3940. PubMed ID: 37818049
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma.
    Zhang L; Zong L; Li W; Ning L; Zhao Y; Wang S; Wang L
    Front Genet; 2023; 14():1120827. PubMed ID: 37124619
    [No Abstract]   [Full Text] [Related]  

  • 119. Construction of a risk model and prediction of prognosis and immunotherapy based on cuproptosis-related LncRNAs in the urinary system pan-cancer.
    Ma Z; Liang H; Cui R; Ji J; Liu H; Liu X; Shen P; Wang H; Wang X; Song Z; Jiang Y
    Eur J Med Res; 2023 Jun; 28(1):198. PubMed ID: 37370148
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Construction and significance of a breast cancer prognostic model based on cuproptosis-related genotyping and lncRNAs.
    Sun L; Chen X; Li F; Liu S
    J Formos Med Assoc; 2024 May; ():. PubMed ID: 38772805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.